CMS Introduces ACO LEAD: Revolutionizing Medicare's Value-Based Care
Discover how CMS's ACO LEAD model enhances Medicare's value-based care, addressing provider participation challenges and improving care for high-need patients.
Discover how CMS's ACO LEAD model enhances Medicare's value-based care, addressing provider participation challenges and improving care for high-need patients.
Discover how CMS's new pilot program will improve prior authorization in Medicare Advantage. Learn about data transparency and compliance implications for insurers.
Discover vulnerabilities in the ACA marketplace as GAO reveals risks of fraudulent applications. Learn how to protect public funds—click for insights!
Senators introduce bill to stop AI-driven prior authorization pilot program in Traditional Medicare, citing risks to seniors' access to care and provider burden. Legislative effort targets CMS's WISeR model set for 2026 rollout.
Key regulatory and legislative developments shaping U.S. healthcare and insurance in late 2025, including APTC expirations, CMS innovations, FDA initiatives, and congressional healthcare policy efforts.
CMS's current inclusion of noncovered self-administered drug prices in Medicare Part B payment calculations inflates costs for Stelara biosimilars. OIG recommends revising pricing methodology to achieve savings.
U.S. states leverage unused ACA Marketplace premiums to fund abortion services for low-income and uninsured populations, navigating legal frameworks under Section 1303 and CMS guidance challenges. Insight into regulatory compliance and health policy impacts.
CMS 2027 Proposed Rule aims to modernize Medicare Advantage and Part D programs with updates to quality metrics, risk adjustment models, and beneficiary protections. Key changes include Star Ratings revisions, incorporation of Inflation Reduction Act drug pricing provisions, and requests for stakeholder feedback on quality bonus payments and care coordination.
CMS has published 24 quality and efficiency measures for Medicare programs, emphasizing digital data use and targeting chronic conditions and safety priorities. Public commentary is open through January 6.
CMS reviews Obamacare enhanced subsidy issues; VA plans healthcare workforce reductions; vaccine injury program advisory panel to meet post-Christmas.